337 related articles for article (PubMed ID: 29701673)
1. T Cell Calcium Signaling Regulation by the Co-Receptor CD5.
Freitas CMT; Johnson DK; Weber KS
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701673
[TBL] [Abstract][Full Text] [Related]
2. Naïve helper T cells with high CD5 expression have increased calcium signaling.
Freitas CMT; Hamblin GJ; Raymond CM; Weber KS
PLoS One; 2017; 12(5):e0178799. PubMed ID: 28562659
[TBL] [Abstract][Full Text] [Related]
3. CD5, an Undercover Regulator of TCR Signaling.
Voisinne G; Gonzalez de Peredo A; Roncagalli R
Front Immunol; 2018; 9():2900. PubMed ID: 30581443
[TBL] [Abstract][Full Text] [Related]
4. CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.
Matson CA; Choi S; Livak F; Zhao B; Mitra A; Love PE; Singh NJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14342-14353. PubMed ID: 32513716
[TBL] [Abstract][Full Text] [Related]
5. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
Cho H; Kang H; Lee HH; Kim CW
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
[TBL] [Abstract][Full Text] [Related]
6. CD5, an important regulator of lymphocyte selection and immune tolerance.
Raman C
Immunol Res; 2002; 26(1-3):255-63. PubMed ID: 12403363
[TBL] [Abstract][Full Text] [Related]
7. CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.
Blaize G; Daniels-Treffandier H; Aloulou M; Rouquié N; Yang C; Marcellin M; Gador M; Benamar M; Ducatez M; Song KD; Burlet-Schiltz O; Saoudi A; Love PE; Fazilleau N; Gonzalez de Peredo A; Lesourne R
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12969-12979. PubMed ID: 32434911
[TBL] [Abstract][Full Text] [Related]
8. A computational study of co-inhibitory immune complex assembly at the interface between T cells and antigen presenting cells.
Su Z; Dhusia K; Wu Y
PLoS Comput Biol; 2021 Mar; 17(3):e1008825. PubMed ID: 33684103
[TBL] [Abstract][Full Text] [Related]
9. CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204.
Domingues RG; Lago-Baldaia I; Pereira-Castro I; Fachini JM; Oliveira L; Drpic D; Lopes N; Henriques T; Neilson JR; Carmo AM; Moreira A
Eur J Immunol; 2016 Jun; 46(6):1490-503. PubMed ID: 27005442
[TBL] [Abstract][Full Text] [Related]
10. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
11. AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells.
Lu X; Axtell RC; Collawn JF; Gibson A; Justement LB; Raman C
J Immunol; 2002 Jun; 168(11):5612-20. PubMed ID: 12023358
[TBL] [Abstract][Full Text] [Related]
12. The multiple faces of CD5.
Burgueño-Bucio E; Mier-Aguilar CA; Soldevila G
J Leukoc Biol; 2019 May; 105(5):891-904. PubMed ID: 30676652
[TBL] [Abstract][Full Text] [Related]
13. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
[TBL] [Abstract][Full Text] [Related]
14. The calcium feedback loop and T cell activation: how cytoskeleton networks control intracellular calcium flux.
Joseph N; Reicher B; Barda-Saad M
Biochim Biophys Acta; 2014 Feb; 1838(2):557-68. PubMed ID: 23860253
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells.
Sen G; Bikah G; Venkataraman C; Bondada S
Eur J Immunol; 1999 Oct; 29(10):3319-28. PubMed ID: 10540344
[TBL] [Abstract][Full Text] [Related]
16. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
17. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts.
Poh SL; Linn YC
Cancer Immunol Immunother; 2016 May; 65(5):525-36. PubMed ID: 26961084
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of CD5
Wlasiuk P; Niedzielski A; Skorka K; Karczmarczyk A; Zaleska J; Zajac M; Putowski M; Pac-Kozuchowska E; Giannopoulos K
Clin Exp Med; 2016 Nov; 16(4):503-509. PubMed ID: 26319791
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.
Soldevila G; Raman C; Lozano F
Curr Opin Immunol; 2011 Jun; 23(3):310-8. PubMed ID: 21482089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
